Dr. George Poste is Chief Scientist, Complex Adaptive Systems Initiative (CASI) at Arizona State University. This program links expertise across the university in research on synthetic biology, ubiquitous sensing and Healthcare informatics for personalized medicine. He founded the Biodesign Institute at ASU and served as Director from 2003 to 2009. He serves on the Board of Monsanto, Exelixis, Caris Life Sciences, and the SAB of Synthetic Genomics. From 1992 to 1999 he was Chief Science and Technology Officer and President, R&D of SmithKline Beecham, where he was associated with the successful registration of 31 drug, vaccine and diagnostic products. In 2004 he was named as ‘R&D Scientist of the Year’ by R&D Magazine, in 2006 he received the Einstein award from the Global Business Leadership Council and in 2009 received the Scrip Lifetime Achievement award voted by the leadership of the global pharmaceutical industry.
He is a Fellow of the Royal Society, the Royal College of Pathologists and the UK Academy of Medicine, a Distinguished Fellow at the Hoover Institution, Stanford University and a member of the Council for Foreign Relations. He served as a member of the Defense Science Board from 2003 to 2009 and Health Board of the US Department of Defense and is currently a member of the U.S. Institute of Medicine Board on Global Health. He has served on Advisory Committees for U.S. government agencies in defense, national security and healthcare.
